Vitamin E supplementation in the treatment of asthma: a randomised controlled trial Source: Eur Respir J 2003; 22: Suppl. 45, 104s Year: 2003
Curcumin Improves Therapy of Moderate Partially Controlled Asthma: Placebo-controlled, single blind study Source: International Congress 2019 – Clinical studies of asthma treatments Year: 2019
The ARROW Study: A Phase 2, Prospective, Randomized, Double-Blind, Placebo-Controlled Study of Selonsertib in Subjects with Pulmonary Arterial Hypertension Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017
Late Breaking Abstract - Safety and Performance of Total Lung Access to Peripheral Nodules in prospective, multi-center study Source: International Congress 2019 – Interventional pulmonology: a mixture of spices Year: 2019
Real World Effects of Medications for COPD - a UK Population-Based Non-Interventional Cohort Study With Validation Against Randomised Trial Results Source: International Congress 2019 – COPD treatment: cohorts and real-world studies Year: 2019
Effect of High-Flow Oxygen on Exercise Performance In COPD. A Randomized Crossover Trial. Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease Year: 2020
Home Noninvasive Ventilation with Built-in Software in Chronic Hypercapnic COPD Patients: a Mid-term Prospective, Multicenter, Randomized, Controlled Trial Source: International Congress 2018 – New insights in the management of chronic respiratory failure Year: 2018
Evaluation of vitamin D in bronchial asthma and the effect of vitamin D supplementation on asthma severity and control: A randomised control trial Source: International Congress 2014 – Asthma: clinical problems Year: 2014
A randomized, double-blind, placebo-controlled of vitamin D3 for Irish children with asthma: Baseline data Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management Year: 2014
Combination of pentoxifylline and vitamin E for the treatment of sarcoidosis: Retrospective analysis Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016
Comparison of Clinical Efficacy and Safety between ultraLABAs and ultraLAMAs in Patients with COPD: A Systemic Review with a Meta-Analysis of Randomized Controlled Trials Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
Development of the Severe Respiratory Insufficiency application-a randomized controlled trial- Source: Virtual Congress 2020 – Non-invasive ventilation during acute and chronic respiratory failure: technical aspects, adherence and effects Year: 2020
Plasma levels of acute phase proteins in patients from the multicenter longitudinal French Cohort in Lung Transplantation (COLT): a pilot study Source: Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome Year: 2020
Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019
Randomized Phase III Trial Assessing Regional Lung Function for Lung Transplant by Hyperpolarized 129Xenon Gas MRI Source: Virtual Congress 2020 – Imaging-based phenotyping in pulmonary disease Year: 2020
Late Breaking Abstract: High-dose vitamin D3 during intensive phase treatment of pulmonary tuberculosis: A double-blind randomised controlled trial Source: Annual Congress 2010 - Clinical tuberculosis Year: 2010
Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2) Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis Year: 2020
Vitamin D supplementation in childhood asthma: a systematic review and meta-analysis of randomised controlled trials Source: ERJ Open Res, 8 (1) 00662-2021; 10.1183/23120541.00662-2021 Year: 2022
Safety and Tolerability of Combination Therapy with Nintedanib and Pirfenidone for Idiopathic Pulmonary Fibrosis: A Multicenter, Retrospective, Observational Study in Japan Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020
Late Breaking Abstract - Supplementation of iron in pulmonary hypertension (SIPHON): results from a randomised controlled crossover trial Source: International Congress 2019 – Pulmonary hypertension: new therapeutic pathways and modalities Year: 2019